This company has shut down. Ionpath is no longer operating.
Explore the Startup GraveyardIonpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Ionpath's investors include Samsara BioCapital, Thermo Fisher Scientific, Bossa Invest, Vertical Venture Partners, Genoa Ventures.
Ionpath is headquartered in Menlo Park, United States.
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.
Ionpath is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ionpath — Funding & Investors." VCBacked, May 11, 2022, https://www.vcbacked.co/company/ionpath. Accessed September 30, 2026.
VCBacked. (2022). Ionpath — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ionpath
{{cite web |title=Ionpath — Funding & Investors |url=https://www.vcbacked.co/company/ionpath |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated